AVBP Stock Analysis: Buy, Sell, or Hold?
AVBP - ArriVent BioPharma, Inc. Common Stock
$30.60
0.06 (0.20%)
▲
5d:
+0.33%
30d:
+7.67%
90d:
+25.87%
BUY
HIGH Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 3.1/10
Get Alerted When AVBP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AVBP shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: AVBP shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: AVBP is currently trading at $30.60, which is considered slightly high relative to its 30-day fair value range of $27.45 to $30.70.
Technical Outlook: Technically, AVBP is in a strong uptrend. Immediate support is located at $28.31, while resistance sits at $33.62.
Market Sentiment: AVBP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.10 (+37.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AVBP is in a strong uptrend. Immediate support is located at $28.31, while resistance sits at $33.62.
Market Sentiment: AVBP has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.10 (+37.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$27.45 -
$30.70
Company Quality Score
60/100
(BUY)
Options IV Signal
48th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- NEUTRAL: Options fairly priced (IV 48th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.9% below Wall St target ($42.10)
Trading Range Analysis
30-Day Trading Range
$27.45 -
$30.70
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$6.33
(20.7%)
Support & Resistance Levels
Support Level
$28.31
Resistance Level
$33.62
Current Trend
Strong Uptrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.78
Wall Street Target
$42.10
(+37.9%)
Share & Embed Analysis
Last updated: June 15, 2026 1:21 PM ET
Data refreshes hourly during market hours. Next update: 2:21 PM
Data refreshes hourly during market hours. Next update: 2:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVBP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$439 | 57 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$198 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 66 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 62 BUY |
